drugset / Trial / NCT07411794

Dexmedetomidine vs Midazolam in Coronary Artery By-pass Surgery

NCT07411794 ↗

Completed 50 enrolled Cumhuriyet University
RandomizedParallel-groupQuadruple-blindOther

Summary

The aim is to compare the incidence of postoperative delirium following coronary artery bypass grafting (CABG) between patients receiving dexmedetomidine and those receiving midazolam infusions.

Timeline

Start
2026-01-15
Primary completion
2026-05-26
Completion
2026-06-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.3 ug/kg Intravenous
Comparator Dexmedetomidine Other / unclassified 0.7 ug/kg Intravenous
Comparator Midazolam Small molecule 0.03 mg/kg Intravenous
Comparator Midazolam Small molecule 0.06 mg/kg Intravenous

Indications